{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:07:38Z","timestamp":1795061258820,"version":"4.10.2"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KR2291\/4-1\/MA 2183\/1-1"],"award-info":[{"award-number":["KR2291\/4-1\/MA 2183\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.04.046","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T07:34:29Z","timestamp":1524728069000},"page":"329-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Design and biological evaluation of tetrahydro-\u03b2-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors"],"prefix":"10.1016","volume":"152","author":[{"given":"Michel","family":"Leonhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4752-2418","authenticated-orcid":false,"given":"Andreas","family":"Sellmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver H.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"Elz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-9656","authenticated-orcid":false,"given":"Siavosh","family":"Mahboobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.04.046_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/febs.12079","article-title":"Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes","volume":"280","author":"Li","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2018.04.046_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acs.jmedchem.5b01525","article-title":"Design, synthesis, and pharmacological evaluation of novel N-Acylhydrazone derivatives as potent histone deacetylase 6\/8 dual inhibitors","volume":"59","author":"Rodrigues","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2014.08.001","article-title":"Drugging the HDAC6\u2013HSP90 interplay in malignant cells","volume":"35","author":"Kr\u00e4mer","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.04.046_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ejmech.2017.10.040","article-title":"Recent advances in the discovery of potent and selective HDAC6 inhibitors","volume":"143","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acs.jmedchem.5b01342","article-title":"Discovery of selective histone deacetylase 6 inhibitors using the quinazoline as the cap for the treatment of cancer","volume":"59","author":"Yang","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib6","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1016\/j.bmc.2014.05.001","article-title":"Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors","volume":"22","author":"Tashima","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.leukres.2012.02.026","article-title":"HDAC6 as a target for antileukemic drugs in acute myeloid leukemia","volume":"36","author":"Hackanson","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2018.04.046_bib8","first-page":"2050","article-title":"Targeting HDACs: a promising therapy for Alzheimer's disease","volume":"22","author":"Xu","year":"2011","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.04.046_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tips.2009.09.007","article-title":"HDAC2: a critical factor in health and disease","volume":"30","author":"Kr\u00e4mer","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2018.04.046_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/apt.13008","article-title":"Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases","volume":"41","author":"Felice","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2018.04.046_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/156800910791054149","article-title":"Inhibitors of HDACs - effective drugs against cancer?","volume":"10","author":"M\u00fcller","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2018.04.046_bib12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","article-title":"Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors","volume":"19","author":"Bradbury","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2018.04.046_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.20200","article-title":"Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives","volume":"32","author":"Pontiki","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.04.046_bib14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2012.06.014","article-title":"Development and therapeutic impact of HDAC6-selective inhibitors","volume":"84","author":"Dallavalle","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib15","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1021\/jm4001659","article-title":"Development and therapeutic implications of selective histone deacetylase 6 inhibitors","volume":"56","author":"Kalin","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib17","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/1078-0432.CCR-11-3144","article-title":"Romidepsin for cutaneous T-cell lymphoma","volume":"18","author":"Prince","year":"2012","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.04.046_bib18","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40265-014-0275-8","article-title":"Belinostat: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2018.04.046_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40265-015-0388-8","article-title":"Panobinostat: first global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2018.04.046_bib20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/1756-185X.12501","article-title":"A\u00a0novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model","volume":"18","author":"Lee","year":"2014","journal-title":"Int. J. Rheumatol. Dis."},{"key":"10.1016\/j.ejmech.2018.04.046_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.intimp.2013.03.016","article-title":"Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects","volume":"16","author":"Vishwakarma","year":"2013","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2018.04.046_bib22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2011.07.002","article-title":"Histone\/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells","volume":"23","author":"Beier","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2018.04.046_bib24","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1128\/MCB.21.18.6312-6321.2001","article-title":"Identification of a signal-responsive nuclear export sequence in class II histone deacetylases","volume":"21","author":"McKinsey","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and Cell\u2013Cell interactions","volume":"18","author":"Valenzuela-Fernandez","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib26","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1016\/j.bmc.2013.04.036","article-title":"Structural basis for the design and synthesis of selective HDAC inhibitors","volume":"21","author":"Di Micco","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2017.04.013","article-title":"Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors","volume":"135","author":"De Vreese","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib28","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.7b01593","article-title":"Marbostat-100 defines a new class of potent and selective antiinflammatory and antirheumatic histone deacetylase 6 inhibitors","author":"Sellmer","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib29","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1021\/jm502011f","article-title":"Design and synthesis of orally bioavailable aminopyrrolidinone histone deacetylase-6 (HDAC6) inhibitors","volume":"58","author":"Lin","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib30","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib31","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2018.04.046_bib32","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.04.046_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/jm200773h","article-title":"Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ t-regulatory cells","volume":"55","author":"Kalin","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib34","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1016\/j.bmc.2006.06.021","article-title":"Synthesis and cytotoxic activities of \u03b2-carboline amino acid ester conjugates","volume":"14","author":"Zhao","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tetasy.2007.12.017","article-title":"Highly stereoselective Pictet\u2013Spengler reaction of d-tryptophan methyl ester with piperonal: convenient syntheses of Cialis (Tadalafil), 12a-epi-Cialis, and their deuterated analogues","volume":"19","author":"Shi","year":"2008","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2018.04.046_bib36","author":"Daugan"},{"key":"10.1016\/j.ejmech.2018.04.046_bib37","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1021\/jm0300577","article-title":"The discovery of Tadalafil:\u2009 a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1\u2032,2\u2032:1,6]pyrido[3,4-b]indole-1,4-dione analogues","volume":"46","author":"Daugan","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tetasy.2009.01.026","article-title":"Syntheses of chiral 1,3-disubstituted tetrahydro-\u03b2-carbolines via CIAT process: highly stereoselective Pictet\u2013Spengler reaction of d-tryptophan ester hydrochlorides with various aldehydes","volume":"20","author":"Xiao","year":"2009","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2018.04.046_bib39","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/jm200676f","article-title":"Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives","volume":"54","author":"Robaa","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib40","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/cber.19110440309","article-title":"\u00dcber die Bildung von Isochinolin-derivaten durch Einwirkung von Methylal auf Phenyl\u00e4thylamin, Phenylalanin und Tyrosin","volume":"44","author":"Pictet","year":"1911","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.ejmech.2018.04.046_bib41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/jm00263a036","article-title":"Agents acting on the central nervous system. 15. 2-Substituted 1,2,3,4,6,7,12,12a-octahydropyrazino [2\u2032,1\u2032:6,1]pyrido[3,4-b]indoles. New class of central nervous system depressants","volume":"16","author":"Saxena","year":"1973","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/jm00358a008","article-title":"beta-Carbolines as benzodiazepine receptor ligands. 1. Synthesis and benzodiazepine receptor interaction of esters of beta-carboline-3-carboxylic acid","volume":"26","author":"Lippke","year":"1983","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/jm00263a037","article-title":"Epimeric forms of quaternary derivatives of atropine","volume":"16","author":"Barlow","year":"1973","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib44","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/jo00085a054","article-title":"Stereospecificity in the reaction of tetrahydro-beta-carboline-3-carboxylic acids with isocyanates and isothiocyanates - kinetic vs thermodynamic control","volume":"59","author":"Lopez-Rodriguez","year":"1994","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib45","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1080\/00397919008053104","article-title":"Synthesis and reactivity of \u03b2-carboline-hydantoin systems","volume":"20","author":"Brana","year":"1990","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2018.04.046_bib46","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.bmc.2009.04.033","article-title":"Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-\u03b1 converting enzyme (TACE) inhibitors","volume":"17","author":"Park","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib47","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1021\/jm300618u","article-title":"Indole-derived psammaplin a analogues as epigenetic modulators with multiple inhibitory activities","volume":"55","author":"Pereira","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib48","first-page":"28","article-title":"A\u00a0facile synthesis of \u03b2-carbolines and studies on their antimicrobial activities","volume":"4","author":"Lingam","year":"2008","journal-title":"Indian J. Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib49","series-title":"Preparation of New Derivatives of 1,2,3,4,6,7,12,12a-octahydropyrazino[1\u2032,2\u2032:1,6]pyrido[3,4-b]indoles for Therapeutic Use as Sedatives","author":"Fourtillan","year":"2008"},{"key":"10.1016\/j.ejmech.2018.04.046_bib50","first-page":"22","article-title":"First highly stereocontrolled synthesis of tetrahydro trans-\u03b2-carboline derivatives by exploiting the influence of a cyclic amide","volume":"2","author":"Vedantham","year":"2013","journal-title":"Arkivoc"},{"key":"10.1016\/j.ejmech.2018.04.046_bib51","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1021\/jo025793h","article-title":"First stereoselective synthesis of 2-Deoxy-\u03b1-d-ribosyl-1-phosphate:\u2009 novel application of crystallization-induced asymmetric transformation","volume":"67","author":"Komatsu","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib52","series-title":"Nov. Opt. Resolut. Technol","first-page":"83","article-title":"Racemization, optical resolution and crystallization-induced asymmetric transformation of amino acids and pharmaceutical intermediates","author":"Yoshioka","year":"2007"},{"key":"10.1016\/j.ejmech.2018.04.046_bib53","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/ejoc.200901378","article-title":"An efficient and general method for the stereodivergent syntheses of tadalafil-like tetracyclic compounds","volume":"2010","author":"Xiao","year":"2010","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib54","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.bmc.2011.03.065","article-title":"Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity","volume":"19","author":"Motoshima","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib55","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1021\/jm00168a036","article-title":"Evolution of a series of peptidoleukotriene antagonists: synthesis and structure-activity relationships of 1,6-disubstituted indoles and indazoles","volume":"33","author":"Brown","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2005.12.144","article-title":"Characterization of the two catalytic domains in histone deacetylase 6","volume":"341","author":"Zou","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2018.04.046_bib57","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib58","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1073\/pnas.1718823114","article-title":"Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors","volume":"114","author":"Porter","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2018.04.046_bib59","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in\u00a0vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2018.04.046_bib60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.04.046_bib61","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/MCB.01500-09","article-title":"The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation","volume":"30","author":"Zupkovitz","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.04.046_bib62","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","article-title":"Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility","volume":"21","author":"Montgomery","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2018.04.046_bib63","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"Montgomery","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2018.04.046_bib64","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1101\/gad.1809209","article-title":"Epigenetic control of skull morphogenesis by histone deacetylase 8","volume":"23","author":"Haberland","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2018.04.046_bib65","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/jm00165a028","article-title":"Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogs of 6-(benzyloxy)-4-(methoxymethyl)-.beta.-carboline-3-carboxylic acid ethyl ester","volume":"33","author":"Hollinshead","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib66","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0040-4020(01)81637-9","article-title":"Synthesis of pentacyclic \u03b2-carbolike and 1,4-benzodiazepine hybrid molecules by dehydrogenation-transamination of quinazolino-tetrahydro-\u03b2-carbolines","volume":"43","author":"Beugelmans-Verrier","year":"1987","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.04.046_bib67","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/S0040-4020(01)85462-4","article-title":"Synthesis of \u03b2-carboline-benzodiazepine hybrid molecules and their \u201camputated\u201d analogues as novel ligands of the benzodiazepine receptor","volume":"46","author":"Dellouve-Courillon","year":"1990","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.04.046_bib68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/ci3003655","article-title":"Identification of novel amino acid derived CCK-2R antagonists as potential antiulcer agent: homology modeling, design, synthesis, and pharmacology","volume":"53","author":"Gupta","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.04.046_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jlac.199319930125","article-title":"Synthesis of enantiomerically pure tetrahydro-2-methylharman","volume":"2","author":"Shiqi","year":"1993","journal-title":"Liebigs Ann. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib70","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1016\/j.bmcl.2014.09.063","article-title":"Design, synthesis, anti-TMV, fungicidal, and insecticidal activity evaluation of 1,2,3,4-tetrahydro-\u03b2-carboline-3-carboxylic acid derivatives based on virus inhibitors of plant sources","volume":"24","author":"Song","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.04.046_bib71","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/ja00124a002","article-title":"A\u00a0second generation force field for the simulation of proteins, nucleic acids, and organic molecules","volume":"117","author":"Cornell","year":"1995","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.04.046_bib72","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","article-title":"Validation of the general purpose tripos 5.2 force field","volume":"10","author":"Clark","year":"1989","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib73","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00124359","article-title":"A\u00a0new approach to analysis and display of local lipophilicity\/hydrophilicity mapped on molecular surfaces","volume":"7","author":"Heiden","year":"1993","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2018.04.046_bib74","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1021\/jp980230o","article-title":"Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental Methods:\u2009 an analysis of ALOGP and CLOGP methods","volume":"102","author":"Ghose","year":"1998","journal-title":"J.\u00a0Phys. Chem. A"},{"key":"10.1016\/j.ejmech.2018.04.046_bib75","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/leu.2010.114","article-title":"Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation","volume":"24","author":"Buchwald","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2018.04.046_bib76","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1038\/onc.2012.515","article-title":"SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation","volume":"32","author":"Buchwald","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.04.046_bib77","series-title":"HDACHAT Funct. Assess. Inhib. Dev","first-page":"355","article-title":"How to distinguish between the activity of HDAC1-3 and HDAC6 with western blot","author":"Beyer","year":"2017"},{"key":"10.1016\/j.ejmech.2018.04.046_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2018.04.046_bib79","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00432-016-2229-x","article-title":"Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells","volume":"142","author":"Mahendrarajah","year":"2016","journal-title":"J.\u00a0Canc. Res. Clin. Oncol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T09:24:55Z","timestamp":1720257895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418303866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":79,"alternative-id":["S0223523418303866"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.046","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and biological evaluation of tetrahydro-\u03b2-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}